Haleon PLC Sponsored ADR (HLN) vs Takeda Pharmaceutical Co. (TAK)
- Haleon PLC Sponsored ADR HLN 10.13 +1.91%
- Takeda Pharmaceutical Co. TAK 19.67 +1.13%
Haleon PLC Sponsored ADR and Takeda Pharmaceutical Co. are both Drug Manufacturers Specialty & Generic companies. Takeda Pharmaceutical Co. is the larger, with a market value of $61.9B against $43.7B — 1.4× the size. Haleon PLC Sponsored ADR trades at the lower P/E: 22.6× against 29.6×. Haleon PLC Sponsored ADR has the higher net margin (13.8% vs 7.12%) and the lower return on invested capital (0.00% vs 2.88%). Both pay a dividend; Haleon PLC Sponsored ADR yields more (1.95% vs 1.57%). Across the 22 metrics below, Takeda Pharmaceutical Co. leads on 12 and Haleon PLC Sponsored ADR on 10.
Valuation
Profitability
| Metric | HLN | TAK | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 62.22% | 65.85% | 53.94% |
| Operating margin | 17.93% | 11.61% | 0.00% |
| Net margin | 13.79% | 7.12% | 0.00% |
| Free cash flow margin | 0.00% | 24.74% | 0.00% |
| Return on equity | 0.00% | 4.42% | (0.40%) |
| Return on assets | 0.00% | 2.15% | (3.32%) |
| Return on invested capital | 0.00% | 2.88% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack